Beranda › Kanker Paru › Pennsylvania

Uji klinis Kanker Paru di Pennsylvania

57 studi untuk Kanker Paru mencari peserta di lokasi di Pennsylvania.

Kota di Pennsylvania

Teks studi resmi (Bahasa Inggris)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lehigh Valley Hospital-Cedar Crest, Allentown
UPMC Altoona, Altoona
UPMC-Heritage Valley Health System Beaver, Beaver
dan 53 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Abramson Cancer Center of the University of Pennsylvania, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh
WellSpan York Cancer Center, York

Menerima pesertaFase 1/2

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

UPMC Hillman Cancer Center at Butler Health System, Butler
IRMC Cancer Center, Indiana
UPMC Hillman Cancer Center - New Castle, New Castle
dan 2 lainnya

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Geisinger Medical Center, Danville
dan 7 lainnya

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Bryn Mawr Hospital, Bryn Mawr
Penn State Milton S Hershey Medical Center, Hershey
Riddle Memorial Hospital, Media
dan 6 lainnya

Menerima pesertaFase 3

Usia 70 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Bryn Mawr Hospital, Bryn Mawr
dan 12 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT04181060

Empathic Communication Skills (ECS) Training

University of Pennsylvania (Data Collection Only), Philadelphia
Fox Chase Cancer Center (Data Collection Only), Philadelphia

Menerima pesertaSukarelawan sehat diterima

Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05456841

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Bryn Mawr Hospital, Bryn Mawr
dan 14 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06498635

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Alliance Cancer Specialists, Sellersville

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06765109

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Penn State Milton S. Hershey Medical Center, Hershey

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06881784

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Penn State Milton S. Hershey Medical Center-Penn State Cancer Institute ( Site 0059), Hershey
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0068), Lancaster

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06312137

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Alliance Cancer Specialists - Media, Media
Guthrie Medical Group, Sayre

Menerima pesertaFase 3

Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05920356

A Registry for People With Lung Cancer

Thomas Jefferson University Hospital (Data Collection Only), Philadelphia
ALLEGHENY HEALTH NETWORK (Data Collection Only), Pittsburgh

Menerima pesertaStudi observasional

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06424327

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Pittsburgh

Menerima pesertaFase 2

Usia 18 hingga 95 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05061550

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Allegheny Health Network, Pittsburgh

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Hospital of the University of Pennsylvania, Philadelphia
West Penn Allegheny Health, Pittsburgh

Menerima pesertaFase 2/3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07100080

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06287775

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

St. Luke's University Health Network, Bethlehem
Allegheny Cancer Center, Pittsburgh
Reading Hospital - McGlinn Cancer Institute, West Reading

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

USO - Alliance Cancer Specialists, PC, Horsham
Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
UPMC Hillman Cancer Center, Pittsburgh

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

UPMC Hillman Cancer Center, Pittsburgh

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07012031

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Philadelphia

Menerima pesertaFase 1/2

Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07038343

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Fox Chase Cancer Center, Philadelphia

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07185997

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

St. Luke's Physician Group - St. Luke's Cancer Care Associates, Fountain Hill

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06712355

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

Hospital of the University of Pennsylvania, Philadelphia

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07499674

Pemefolacianine for IMI of Lung Cancer

University of Pennsylvania, Philadelphia

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07772895

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

Abramson Cancer Center ( Site 0010), Philadelphia

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06731907

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Christiana Care Health System-Concord Health Center, Chadds Ford
Chambersburg Hospital, Chambersburg
Geisinger Medical Center, Danville
dan 17 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05624996

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT06060613

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Clinical Research Associates of Central Pennsylvania, DuBois

Menerima peserta

Usia 50 hingga 80 · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT07168993

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT07315113

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

UPMC Hillman Cancer Center, Pittsburgh

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT06162221

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Sidney Kimmel Cancer Center, Philadelphia

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07458347

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Allegheny General Hospital, Natrona Heights

Menerima pesertaFase 2

Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT04614103

MOv19-BBz CAR T Cells in FRa+ Cancers

University of Pennsylvania, Philadelphia

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Jun 2026 · NCT07116057

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

Menerima pesertaFase 1/2

Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT05361174

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

UPMC Altoona, Altoona
UPMC-Heritage Valley Health System Beaver, Beaver
UPMC Hillman Cancer Center at Butler Health System, Butler
dan 37 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05642572

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES

Penn Medicine University City, Philadelphia
Perelman Center for Advanced Medicine, Philadelphia
Penn Medicine Washington Square, Philadelphia

Menerima peserta

Usia 35 hingga 89 · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT05968898

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

Menerima pesertaSukarelawan sehat diterima

Usia 50 hingga 77 · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT05679349

Telehealth Collaborative Care Model (CoCM) in Lung Cancer

Abramson Cancer Center at the University of Pennsylvania, Philadelphia

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Mei 2026 · NCT07102147

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Fox Chase Cancer Center, Philadelphia

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT05800587

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.